RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Accelerating Lead Generation
Jun 2009 - 175 pages - $3,835
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
Jun 2010 - 160 pages - $3,995
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
The Drug Discovery Outsourcing Market
Jan 2011 - 99 pages - $3,835
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Cell-Based Assays for Drug Discovery
Aug 2009 - 103 pages - $3,400
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
High throughput screening del
Therapeutic target
Oncology del
Lymphoma del
Year
2000 del

Browse By

Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us